18 May 2013
Keywords: gw, co-promote, flomax, mr, uk, glaxo, wellcome
Article | 17 February 1999
Glaxo Wellcome of the UK and Japan's Yamanouchi Pharma have signed afour-year agreement to jointly promote the latter's once-daily alpha1
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com